Radiobiological basis in management of accidental radiation exposure

International Journal of Radiation Biology

Volumn 86, Issue 8, 2010, Pages 613-635

  Pandey, Badri N ^a   Kumar, Amit ^a   Tiwari, Prabha ^a   Mishra, Kaushala P ^a  

^a BHABHA ATOMIC RESEARCH CENTRE   (India)

Author keywords

accidental radiation exposure; biodosimetry; radiation mitigation; radiation protection; radionuclide decorporation; radionuclides

Indexed keywords

AMERICIUM; BIOLOGICAL MARKER; CESIUM; DEFEROXAMINE; GALLIC ACID; PENICILLAMINE; PENTETIC ACID; PLUTONIUM; RADIOISOTOPE; STRONTIUM; THORIUM; TIRON; URANIUM;

ATOMIC WARFARE; CHROMOSOME ANALYSIS; DOSIMETRY; ELECTRON SPIN RESONANCE; GENOMICS; HUMAN; METABOLOMICS; NONHUMAN; NUCLEAR ACCIDENT; PRIORITY JOURNAL; PROTEOMICS; RADIATION ACCIDENT; RADIATION DOSE; RADIATION EXPOSURE; RADIATION INJURY; RADIATION PROTECTION; RADIOBIOLOGY; REVIEW;

BIOLOGICAL MARKERS; CHROMOSOME ABERRATIONS; ELECTRON SPIN RESONANCE SPECTROSCOPY; GENOMICS; HUMANS; METABOLOMICS; NUCLEAR WARFARE; OCCUPATIONAL EXPOSURE; PROTEOMICS; RADIATION INJURIES; RADIATION PROTECTION; RADIOACTIVE HAZARD RELEASE; RADIOBIOLOGY; RADIOMETRY;

EID: 77955170331     PISSN: 09553002     EISSN: 13623095     Source Type: Journal    
DOI: 10.3109/09553001003746059     Document Type: Review

References (210)

1. Akiyama M, Kyoizumi S, Hirai Y, Hakoda M, Nakamura N, Awa AA. 1990. Studies on chromosome aberrations and HPRT mutations in lymphocytes and GPA mutation in erythrocytes of atomic bomb survivors. Progress in Clinical and Biological Research 340C:69-80.
2. Akiyama M, Nakamura N, Hakoda M, Kyoizumi S, Kushiro J, Hirai Y, Kusunoki Y. 1991. Somatic cell mutations in atomic bomb survivors. Journal of Radiation Research (Tokyo) 32(Suppl.):278-282.
3. Alevritou-Goulielmou H. 2005. Nuclear accidents, consumers perspectives and demands. Journal of Environmental Radioactivity 83:433-435.
4. Ali M, Tiwari P, Kumar A, Mishra KP, Pandey BN. 2009. Correlation of FBX dosimeter and micronucleus assay in radiation dosimetry of gamma chambers. Journal of Environmental, Pathology, Toxicology and Oncology 28:63-73.
5. Amundson SA. 2008. Functional genomics in radiation biology: A gateway to cellular systems-level studies. Radiation and Environmental Biophysics 47:25-31.
6. Amundson SA, Bittner M, Fornace AJ Jr. 2003. Functional genomics as a window on radiation stress signaling. Oncogene 22:5828-5833.
7. Amundson SA, Bittner M, Meltzer P, Trent J, Fornace AJ Jr. 2001a. Biological indicators for the identification of ionizing radiation exposure in humans. Expert Review of Molecular Diagnostics 1:211-219.
8. Amundson SA, Fornace AJ Jr. 2001. Gene expression profiles for monitoring radiation exposure. Radiation Protection Dosimetry 97:11-16.
9. Amundson SA, Grace MB,McLeland CB, EpperlyMW, Yeager A, Zhan Q, Greenberger JS, Fornace AJ Jr. 2004. Human in vivo radiation-induced biomarkers: Gene expression changes in radiotherapy patients. Cancer Research 64:6368-6371.
10. Amundson SA, Lee RA, Koch-Paiz CA, Bittner ML, Meltzer P, Trent JM, Fornace AJ, Jr. 2003. Differential responses of stress genes to low dose-rate gamma irradiation. Molecular Cancer Research 1:445-452.
11. Agency for toxic substances and disease registry (ASTDR). 1990. Toxicological profile for thorium. Atlanta, GA: ASTDR.
12. Agency for toxic substances and disease registry (ASTDR). 1999. Toxicological profile for uranium. Atlanta, GA: ASTDR.
13. Agency for toxic substances and disease registry (ASTDR). 2004a.Toxicological profile for cesium. Atlanta, GA: ASTDR.
14. Agency for toxic substances and disease registry (ASTDR). 2004b. Toxicological profile for americium. Atlanta, GA: ASTDR.
15. Agency for toxic substances and disease registry (ASTDR). 2007. Toxicological profile for plutonium. Atlanta, GA: ASTDR.
16. Barrett A, Jacobs A, Kohn J, Raymond J, Powles RL. 1982. Changes in serum amylase and its isoenzymes after whole body irradiation. British Medical Journal (Clinical Research Ed) 285:170-171.
17. Baverstock K, Williams D. 2006. The Chernobyl accident 20 years on: An assessment of the health consequences and the international response. Environmental Health Perspectives 114:1312-1317.
18. Baverstock K, Williams D. 2007. The Chernobyl accident 20 years on: An assessment of the health consequences and the international response. Ciência and Saúde Coletiva 12:689-698.
19. Bender MA, Awa AA, Brooks AL, Evans HJ, Groer PG, Littlefield LG, Pereira C, Preston RJ, Wachholz BW. 1988. Current status of cytogenetic procedures to detect and quantify previous exposures to radiation. Mutation Research 196:103-159.
20. Bender MA, Gooch PC. 1962. Types and rates of x-ray-induced chromosome aberrations in human blood irradiated in vitro. Proceedings of the National Academy of Sciences of the USA 48:522-532.
21. Bensadoun RJ, Schubert MM, Lalla RV, Keefe D. 2006. Amifostine in the management of radiation-induced and chemo-induced mucositis. Support Care Cancer 14:566-572.
22. Bertho JM, Demarquay C, Frick J, Joubert C, Arenales S, Jacquet N, Sorokine-Durm I, Chau Q, Lopez M, Aigueperse J, Gorin NC, Gourmelon P. 2001. Level of Flt3-ligand in plasma: A possible new bio-indicator for radiation-induced aplasia. International Journal of Radiation Biology 77:703-712.
23. Bigbee WL, Jensen RH, Veidebaum T, Tekkel M, Rahu M, Stengrevics A, Auvinen A, Hakulinen T, Servomaa K, Rytomaa T, Obrams GI, Boice JD Jr. 1997. Biodosimetry of Chernobyl clean-up workers from Estonia and Latvia using the glycophorin A in vivo somatic cell mutation assay. Radiation Research 147:215-224.
24. Blakely WF, Carr Z, Chu MC, Dayal-Drager R, Fujimoto K, Hopmeir M, Kulka U, Lillis-Hearne P, Livingston GK, Lloyd DC, Maznyk N, Perez Mdel R, Romm H, Takashima Y, Voisin P, Wilkins RC, Yoshida MA. 2009. WHO 1st consultation on the development of a global biodosimetry laboratories network for radiation emergencies (BioDoseNet). Radiation Research 171:127-139.
25. Blakely WF, Ossetrova NI, Manglapus GL, Salter CA, Levine IH, Jackson WE, Grace MB, Prasanna PGS, Sandgren DJ, Ledney GD. 2007. Amylase and blood cell count hematological radiation-injury biomarkers in a rhesus monkey radiation model-use of multiparameter and integrated biological dosimetry. Radiation Measurements 42:1164-1170.
26. Borge OJ, Adolfsson J, Jacobsen AM. 1999. Lymphoid-restricted development from multipotent candidate murine stem cells: Distinct and complimentary functions of the c-kit and flt3- ligands. Blood 94:3781-3790.
27. Brandao-Mello CE, Oliveira AR, Valverde NJ, Farina R, Cordeiro JM. 1991. Clinical and hematological aspects of 137Cs: The Goiania radiation accident. Health Physics 60:31-39.
28. Briner W, Murray J. 2005. Effects of short-term and long-term depleted uranium exposure on open-field behavior and brain lipid oxidation in rats. Neurotoxicology and Teratology 27:135-144.
29. Burdelya LG, Krivokrysenko VI, Tallant TC, Strom E, Gleiberman AS, Gupta D, Kurnasov OV, Fort FL, Osterman AL, Didonato JA, Feinstein E, Gudkov AV. 2008. An agonist of toll-like receptor 5 has radioprotective activity in mouse and primate models. Science 320:226-230.
30. Bussy C, Lestaevel P, Dhieux B, Amourette C, Paquet F, Gourmelon P, Houpert P. 2006. Chronic ingestion of uranyl nitrate perturbs acetylcholinesterase activity and monoamine metabolism in male rat brain. Neurotoxicology 27:245-252.
31. Cassatt DR, Kaminski JM, Hatchett RJ, DiCarlo AL, Benjamin JM, Maidment BW. 2008. Medical countermeasures against nuclear threats: Radionuclide decorporation agents. Radiation Research 170:540-548.
32. Chao NJ. 2007. Accidental or intentional exposure to ionizing radiation: Biodosimetry and treatment options. Experimental Hematology 35:24-27.
33. Chin FK. 2007. Scenario of a dirty bomb in an urban environment and acute management of radiation poisoning and injuries. Singapore Medical Journal 48:950-957.
34. Chumak VV, Sholom SV, Bakhanova EV, Pasalskaya LF, Musijachenko AV. 2005. High precision EPR dosimetry as a reference tool for validation of other techniques. Applied Radiation and Isotopes 62:141-146.
35. Dainiak N, Berger P, Albanese J. 2007. Relevance and feasibility of multi-parameter assessment for management of mass casualties from a radiological event. Experimental Hematology 35:17-23.
36. Dainiak N, Waselenko JK, Armitage JO, MacVittie TJ, Farese AM. 2003. The hematologist and radiation casualties. Hematology American Society of Hematology Education Program 473-496.
37. Dange P, Sarma H, Pandey BN, Mishra KP. 2007. Radiationinduced incidence of thymic lymphoma in mice and its prevention by antioxidants. Journal of Environmental, Pathology, Toxicology and Oncology 26:273-279.
38. Das B, Karuppasamy CV. 2009. Spontaneous frequency of micronuclei among the newborns from high level natural radiation areas of Kerala in the southwest coast of India. International Journal of Radiation Biology 85:272-280.
39. Degteva MO, Shagina NB, Tolstykh EI, Bougrov NG, Zalyapin VI, Anspaugh LR, Napier BA. 2007. An approach to reduction of uncertainties in internal dose reconstructed for the Techa River population. Radiation Protection Dosimetry 127:480-485.
40. Demidenko E, Williams BB, Swartz HM. 2009. Radiation dose prediction using data on time to emesis in the case of nuclear terrorism. Radiation Research 171:310-319.
41. Domingo JL, Llobet JM, Tomas JM, Corbella J. 1987. Acute toxicity of uranium in rats and mice. Bulletin of Environmental Contamination and Toxicology 39:168-174. (Pubitemid 17120406)
42. Donnadieu-Claraz M, Benderitter M, Joubert C, Voisin P. 1999. Biochemical indicators ofwhole-body gamma-radiation effects in the pig. International Journal of Radiation Biology 75:165-174.
43. Durakovic A. 1999. Medical effects of internal contamination with uranium. Croatian Medical Journal 40:49-66.
44. Durbin PW, Kullgren B, Xu J, Raymond KN. 2000. Multidentate hydroxypyridinonate ligands for Pu(IV) chelation in vivo: Comparative efficacy and toxicity in mouse of ligands containing 1,2-HOPO or Me-3,2-HOPO. International Journal of Radiation Biology 76:199-214.
45. Epperly MW, Dixon T, Wang H, Schlesselman J, Franicola D, Greenberger JS. 2008. Modulation of radiation-induced life shortening by systemic intravenous MnSOD-plasmid liposome gene therapy. Radiation Research 170:437-443.
46. Epperly MW, Gretton JE, Sikora CA, Jefferson M, Bernarding M, Nie S, Greenberger JS. 2003. Mitochondrial localization of superoxide dismutase is required for decreasing radiationinduced cellular damage. Radiation Research 160:568-578.
47. Esco R, Lopez P, Bellosta R, Baquedano JE, Mateo P. 1993. Accidental overirradiation syndrome. Radiotherapy and Oncology 28:177-178.
48. Filipy RE, Toohey RE, Kathren RL, Dietert SE. 1995. Deterministic effects of 241Am exposure in the Hanford Americium accident case. Health Physics 69:338-345.
49. Fornace AJ Jr, Amundson SA, Do KT, Meltzer P, Trent J, Bittner M. 2002. Stress-gene induction by low-dose gamma irradiation. Military Medicine 167:13-15.
50. Forster L, Forster P, Lutz-Bonengel S, Willkomm H, Brinkmann B. 2002. Natural radioactivity and human mitochondrial DNA mutations. Proceedings of the National Academy of Sciences of the USA 99:13950-13954.
51. Fukumoto M, Kuwaharaa Y, Ohkubo Y, Wang L. 2006. Analysis of carcinogenic mechanisms of liver cancers induced by chronic exposure to alpha particles from internally deposited Thorotrast. Radiation Measurements 41:1186-1190.
52. Garaj-Vrhovac V, Durinec M, Kopjar N, Orescanin V. 2008. A survey on the cytogenetic status of the Croatian general population by use of the cytokinesis-block micronucleus assay. Mutation Research 649:91-100.
53. Garaj-Vrhovac V, Kopjar N. 2003. The alkaline Comet assay as biomarker in assessment of DNA damage in medical personnel occupationally exposed to ionizing radiation. Mutagenesis 18:265-271.
54. Garaj-Vrhovac V, Kopjar N, Razem D, Vekic B, Miljanic S, Ranogajec-Komor M. 2002. Application of the alkaline comet assay in biodosimetry: Assessment of in vivo DNA damage in human peripheral leukocytes after a gamma radiation incident. Radiation Protection Dosimetry 98:407-416.
55. Gaugler MH, Squiban C, van der Meeren A, Bertho JM, Vandamme M, Mouthon MA. 1997. Late and persistent upregulation of intercellular adhesion molecule-1 (ICAM-1) expression by ionizing radiation in human endothelial cells in vitro. International Journal of Radiation Biology 72:201-209.
56. Gillette NA, Pool RR, Taylor GN, Muggenburg BA, Boecker BB. 1992. Strontium-90 induced bone tumours in beagle dogs: Effects of route of exposure and dose rate. International Journal of Radiation Biology 61:821-831.
57. Ghandhi SA, Yaghoubian B, Amundson SA. 2008. Global gene expression analyses of bystander and alpha particle irradiated normal human lung fibroblasts: Synchronous and differential responses. BMC Medical Genomics 1:63.
58. Ghosh S, Kumar A, Pandey BN, Mishra KP. 2007. Acute exposure of uranyl nitrate causes lipid peroxidation and histopathological damage in brain and bone of Wistar rat. Journal of Environmental, Pathology, Toxicology and Oncology 26:255-261.
59. Gilbert ES, Koshurnikova NA, Sokolnikov ME, Shilnikova NS, Preston DL, Ron E, Okatenko PV, Khokhryakov VF, Vasilenko EK, Miller S, Eckerman K, Romanov SA. 2004. Lung cancer in Mayak workers. Radiation Research 162:505-516.
60. Goans RE, Holloway EC, Berger ME, Ricks RC. 2001. Early dose assessment in criticality accidents. Health Physics 81:446-449.
61. Gomes MA,Wascheck Cde C, Scully C, Almeida Ode P, Bozzo L. 1990. Orofacial manifestations from accidental exposure to Cesium-137 in Goiania, Brazil. Journal of Oral Pathology and Medicine 19:322-325.
62. Gonzalez JC. 2004. Bio-terrorism, dirty bombs, hospitals, and security issues. Journal of Healthcare Protection Management 20:55-59.
63. Gorden AE, Xu J, Raymond KN, Durbin P. 2003. Rational design of sequestering agents for plutonium and other actinides. Chemical Review 103:4207-4282.
64. Goto A, Takebayashi Y, Liu D, Li L, Saiga T, Mori T, Yamadera A, Fukumoto M. 2002. Microdistribution of alpha particles in pathological sections of tissues from thorotrast patients detected by imaging plate autoradiography. Radiation Research 158:54-60.
65. Gotoh E, Tanno Y, Takakura K. 2005. Simple biodosimetry method for use in cases of high-dose radiation exposure that scores the chromosome number of Giemsa-stained druginduced prematurely condensed chromosomes (PCC). International Journal of Radiation Biology 81:33-40. (Pubitemid 40674532)
66. Grdina DJ, Murley JS, Kataoka Y. 2002. Radioprotectants: Current status and new directions. Oncology 63(Suppl. 2):2-10.
67. Greenberger JS, Epperly MW. 2004. Radioprotective antioxidant gene therapy: Potential mechanism of action. Gene Therapy and Molecular Biology 8:31-44.
68. Gross L, Dreyfuss Y. 1990. Prevention of spontaneous and radiation-induced tumors in rats by reduction of food intake. Proceedings of the National Academy of Sciences of the USA 87:6795-6797.
69. Guilmette RA, Hakimi R, Durbin PW, Xu J, Raymond KN. 2003. Competitive binding of Pu and Am with bone mineral and novel chelating agents. Radiation Protection Dosimetry 105:527-534.
70. Hakoda M, Hirai Y, Kyoizumi S, Akiyama M. 1989. Molecular analyses of in vivo hprt mutant T cells from atomic bomb survivors. Environmental and Molecular Mutagenesis 13:25-33.
71. Hall EJ. 2001. Radiobiology for radiobiologists. Philadelphia, PA: Lippincott Williams and Wilkins.
72. Halliwell B, Gutteridge JMC. 1989. Free radicals in biology and medicine. Oxford: Clarendon Press.
73. Herodin F, Grenier N, Drouet M. 2007. Revisiting therapeutic strategies in radiation casualties. Experimental Hematology 35:28-33.
74. Hö llriegl V, Röhmuss M, Oeh U, Roth P. 2004. Strontium biokinetics in humans: Influence of alginate on the uptake of ingested strontium. Health Physics 86:193-196.
75. Hosseinimehr SJ. 2007. Trends in the development of radioprotective agents. Drug Discovery Today 12:794-805.
76. Hu ZZ, Huang H, Cheema A, Jung M, Dritschilo A, Wu CH. 2008. Integrated bioinformatics for radiation-induced pathway analysis from proteomics and microarray data. Journal of Proteomics and Bioinformatics 1:47-60.
77. Huchet A, Belkacemi Y, Frick J, Prat M, Muresan-Kloos I, Altan D, Chapel A, Gorin NC, Gourmelon P, Bertho JM. 2003. Plasma Flt-3 ligand concentration correlated with radiationinduced bone marrow damage during local fractionated radiotherapy. International Journal of Radiation Oncology, Biology and Physics 57:508-515.
78. International Atomic Energy Agency (IAEA). 1988. The radiological accident in Goiania. Vienna: IAEA. STI/PUB/815.
79. International Atomic Energy Agency (IAEA). 1993. The radiological accident in Soreq. Vienna: IAEA. STI/PUB/925.
80. International Atomic Energy Agency (IAEA). 1996. The radiological accident at the Irradiation Facility in Nesvizh. Vienna: IAEA. STI/PUB/1010.
81. International Atomic Energy Agency (IAEA). 2001. Cytogenetic analysis for radiation dose assessment Vienna: IAEA. Technical Report Series: 405. http://www.iaea.org/News Center/PressReleases/2002/prn0209.shtml.
82. International Atomic Energy Agency (IAEA). 2002. Inadequate Control of Worlds Radioactive Sources. Press Release 2002/ 09. Accessed from the website: http://www.iaea.org/News Center/PressReleases/2002/prn0209.shtml.
83. International Commission on Radiological Protection (ICRP) Publication 67. 1994. Age-dependent doses to members of the public from intake of radionuclides: Part 2. Ingestion dose coefficients. Oxford: Elsevier Science.
84. Ikeya M, Miyajima J, Okajima S. 1984. ESR dosimetry for atomic bomb survivors using shell buttons and tooth enamel. Japanese Journal of Applied Physics 23:697-699.
85. Inano H, Onoda M, Inafuku N, Kubota M, Kamada Y, Osawa T, Kobayashi H, Wakabayashi K. 1999. Chemoprevention by curcumin during the promotion stage of tumorigenesis of mammary gland in rats irradiated with gamma-rays. Carcinogenesis 20:1011-1018.
86. Inano H, Onoda M, Inafuku N, Kubota M, Kamada Y, Osawa T, Kobayashi H, Wakabayashi K. 2000. Potent preventive action of curcumin on radiation-induced initiation of mammary tumorigenesis in rats. Carcinogenesis 21:1835-1841.
87. Ishikawa Y, Humphreys JA, Collier CG, Priest ND, Kato Y, Mori T, Machinami R. 1999. Revised organ partition of Thorium- 232 in thorotrast patients. Radiation Research 152:S102-106.
88. Jacob V, Jacob P, Meckbach R, Romanov SA, Vasilenko EK. 2005. Lung cancer in Mayak workers: Interaction of smoking and plutonium exposure. Radiation and Environmental Biophysics 44:119-129.
89. Jaggi JS, Seshan SV,McDevittMR, SgourosG,Hyjek E, Scheinberg DA. 2006. Mitigation of radiation nephropathy after internal alpha-particle irradiation of kidneys. International Journal of Radiation Oncology, Biology and Physics 64:1503-1512.
90. Jarrett DG. 2001. Medical aspects of ionizing radiation weapons. Military Medicine 166:6-8.
91. Jenkins LM, Mazur SJ, Rossi M, Gaidarenko O, Xu Y, Appella E. 2008. Quantitative proteomics analysis of the effects of ionizing radiation in wild type and p53 K317R knock-in mouse thymocytes. Molecular and Cellular Proteomics 7:716-727.
92. Johnston WR. 2008. Database of radiological incidents and related events. Accessed from the website: http://www.johnstonsarchive. net/nuclear/radevents/ index.html
93. Jonah MM, Cerny EA, Rahman YE. 1975. Tissue distribution of EDTA encapsulated within liposomes of varying surface properties. Biochim Biophys Acta 401:336-348.
94. Kerber RA, Till JE, Simon SL, Lyon JL, Thomas DC, Preston- Martin S, Rallison ML, Lloyd RD, Stevens W. 1993. A cohort study of thyroid disease in relation to fallout from nuclear weapons testing. Journal of the American Medical Association 270:2076-2082.
95. Khan RF, Pekar J, Rink WJ, Boreham DR. 2005. Retrospective radiation dosimetry using electron paramagnetic resonance in canine dental enamel.Applied Radiation and Isotopes 62:173-179.
96. Kirsch-Volders M, Sofuni T, Aardema M, Albertini S, Eastmond D, Fenech M, Ishidate M, Jr., Kirchner S, Lorge E, Morita T, Norppa H, Surralles J, Vanhauwaert A, Wakata A. 2003. Report from the in vitro micronucleus assay working group. Mutation Research 540:153-163.
97. Kochupillai N, Verma IC, Grewal MS, Ramalingaswami V. 1976. Downs syndrome and related abnormalities in an area of high background radiation in coastal Kerala. Nature 262:60-61.
98. Kodama Y, Ohtaki K, Awa AA, Nakano M, Itoh M, Nakamura N. 1999. The F value for chromosome aberrations in atomic bomb survivors does not provide evidence for a primary contribution of neutrons to the dose in Hiroshima. Radiation Research 152:558-562.
99. Koenig KL, Goans RE, Hatchett RJ, Mettler FA Jr, Schumacher TA, Noji EK, Jarrett DG. 2005. Medical treatment of radiological casualties: Current concepts. Annals of Emergency Medicine 45:643-652.
100. Krahenbuhl MP, Bess JD, Wilde JL, Vostrotin VV, Suslova KG, Khokhryakov VF, SlaughterDM, Miller SC. 2005. Uncertainties analysis of doses resulting from chronic inhalation of plutonium at theMayak production association. Health Physics 89:33-45.
101. Kreisheimer M, Sokolnikov ME, Koshurnikova NA, Khokhryakov VF, Romanow SA, Shilnikova NS, Okatenko PV, Nekolla EA, Kellerer AM. 2003. Lung cancer mortality among nuclear workers of the Mayak facilities in the former Soviet Union.An updated analysis considering smoking as the main confounding factor. Radiation Environmental Biophysics 42:129-135.
102. Krestinina LY, Preston DL, Ostroumova EV, Degteva MO, Ron E, Vyushkova OV, Stratsev NV, Kossenko MM, Akleyev AV. 2005. Protracted radiation exposure and cancer mortality in the Techa River Cohort. Radiation Research 164:602-611.
103. Kumar A. 2008. Radiological and chemical toxic effects of heavy metal radionuclides and modification of their impact on health. BARC. PhD. Mumbai University. Mumbai, India.
104. Kumar A, Ali M, Mishra P, Pandey BN, Sharma P, Mishra KP. 2009. Thorium-induced neurobehavioural and neurochemical alterations in Swiss mice. International Journal of Radiation Biology 85:338-347.
105. Kumar A, Mishra P, Ghosh S, Sharma P, Ali M, Pandey BN, Mishra KP. 2008. Thorium-induced oxidative stress mediated toxicity in mice and its abrogation by Diethylenetriamine pentaacetate. International Journal of Radiation Biology 84:337-349.
106. Kurttio P, Harmoinen A, Saha H, Salonen L, Karpas Z, Komulainen H, Auvinen A. 2006. Kidney toxicity of ingested uranium from drinking water. American Journal of Kidney Diseases 47:972-982.
107. Kyoizumi S, Kusunoki Y, Hayashi T. 2005. Flow cytometric measurement of mutant T cells with altered expression of TCR: Detecting somatic mutations in humans and mice. Methods of Molecular Biology 291:197-204.
108. Lanz C, Patterson AD, Slavik J, Krausz KW, Ledermann M, Gonzalez FJ, Idle JR. 2009. Radiation metabolomics. 3. Biomarker discovery in the urine of gamma-irradiated rats using a simplified metabolomics protocol of gas chromatography- mass spectrometry combined with random forests machine learning algorithm. Radiation Research 172:198-212.
109. Lazutka JR. 1996. Chromosome aberrations and rogue cells in lymphocytes of Chernobyl clean-up workers. Mutation Research 350:315-329.
110. Leonard A, Rueff J, Gerber GB, Leonard ED. 2005. Usefulness and limits of biological dosimetry based on cytogenetic methods. Radiation Protection Dosimetry 115:448-454.
111. Lestaevel P, Houpert P, Bussy C, Dhieux B, Gourmelon P, Paquet F. 2005. The brain is a target organ after acute exposure to depleted uranium. Toxicology 212:219-226.
112. Linard C, Griffiths NM, Esposito V, Aigueperse J, Gourmelon P. 1997. Changes in gut neurotensin and modified colonic motility following whole-body irradiation in rat. International Journal of Radiation Biology 71:581-588.
113. Lloyd DC, Edwards AA, Leonard A, Deknudt GL, Verschaeve L, Natarajan AT, Darroudi F, Obe G, Palitti F, Tanzarella C, et al. 1992. Chromosomal aberrations in human lymphocytes induced in vitro by very low doses of X-rays. International Journal of Radiation Biology 61:335-343.
114. Lucas JN, Hill FS, Chen AM, Burk CE. 1997. A rapid method for measuring pericentric inversions using fluorescence in situ hybridization (FISH). International Journal of Radiation Biology 71:29-33.
115. Lutgens L, Lambin P. 2007. Biomarkers for radiation-induced small bowel epithelial damage: An emerging role for plasma Citrulline. World Journal of Gastroenterology 13:3033-3042.
116. Lutgens LC, Deutz NE, Gueulette J, Cleutjens JP, Berger MP, Wouters BG, von Meyenfeldt MF, Lambin P. 2003. Citrulline: A physiologic marker enabling quantitation and monitoring of epithelial radiation-induced small bowel damage. International Journal of Radiation Oncology, Biology and Physics 57:1067-1074.
117. MacVittie TJ, Farese AM, Jackson W 3rd. 2005. Defining the full therapeutic potential of recombinant growth factors in the post radiation-accident environment: The effect of supportive care plus administration of G-CSF. Health Physics 89:546-555.
118. Marchetti F, Coleman MA, Jones IM, Wyrobek AJ. 2006. Candidate protein biodosimeters of human exposure to ionizing radiation. International Journal of Radiation Biology 82:605-639.
119. Martin PR, Berdychevski RE, Subramanian U, Blakely WF, Prasanna PG. 2007. Sample tracking in an automated cytogenetic biodosimetry laboratory for radiation mass casualties. Radiation Measurements 42:1119-1124.
120. McDiarmid MA, Hooper FJ, Squibb K, McPhaul K, Engelhardt SM, Kane R, DiPino R, Kabat M. 2002. Health effects and biological monitoring results of Gulf War veterans exposed to depleted uranium. Military Medicine 167:123-124.
121. McDiarmid MA, Keogh JP, Hooper FJ, McPhaul K, Squibb K, Kane R, DiPino R, Kabat M, Kaup B, Anderson L, Hoover D, Brown L, Hamilton M, Jacobson-Kram D, Burrows B, Walsh M. 2000. Health effects of depleted uranium on exposed Gulf War veterans. Environmental Research 82:168-180.
122. McGeoghegan D, GilliesM, Riddell AE, Binks K. 2003. Mortality and cancer morbidity experience of female workers at the British Nuclear Fuels Sellafield plant, 1946-1998. American Journal of Industrial Medicine 44:653-663.
123. Miller SC, Liu G, Bruenger FW, Lloyd RD. 2006. Efficacy of orally administered amphipathic polyaminocarboxylic acid chelators for the removal of plutonium and americium: Comparison with injected Zn-DTPA in the rat. Radiation Protection Dosimetry 118:412-420.
124. Muggenburg BA, Guilmette RA, Hahn FF, Diel JH, Mauderly JL, Seilkop SK, Boecker BB. 2008. Radiotoxicity of inhaled (239)PuO(2) in dogs. Radiation Research 170:736-757.
125. Muggenburg BA, Guilmette RA, Mewhinney JA, Gillett NA, Mauderly JL, Griffith WC, Diel JH, Scott BR, Hahn FF, Boecker BB. 1996. Toxicity of inhaled plutonium dioxide in beagle dogs. Radiation Research 145:361-381.
126. Nagano J, Kono S, Preston DL, Moriwaki H, Sharp GB, Koyama K, Mabuchi K. 2000. Bladder-cancer incidence in relation to vegetable and fruit consumption: A prospective study of atomic-bomb survivors. International Journal of Cancer 86:132-138.
127. Nair MK, Nambi KS, Amma NS, Gangadharan P, Jayalekshmi P, Jayadevan S, Cherian V, Reghuram KN. 1999. Population study in the high natural background radiation area in Kerala, India. Radiation Research 152:S145-148.
128. Nair RR, Rajan B, Akiba S, Jayalekshmi P, Nair MK, Gangadharan P, Koga T, Morishima H, Nakamura S, Sugahara T. 2009. Background radiation and cancer incidence in Kerala, India-Karanagappally cohort study. Health Physics 96:55-66.
129. Nakamura N, Katanic JF, Miyazawa C. 1998. Contamination from possible solar light exposures in ESRdosimetry using human tooth enamel. Journal of Radiation Research (Tokyo) 39:185-191.
130. Natarajan AT, Santos SJ, Darroudi F, Hadjidikova V, Vermeulen S, Chatterjee S, Berg M, Grigorova M, Sakamoto-Hojo ET, Granath F, Ramalho AT, Curado MP. 1998. 137Cesiuminduced chromosome aberrations analyzed by fluorescence in situ hybridization: Eight years follow-up of the Goiania radiation accident victims. Mutation Research 400:299-312.
131. Nenot JC. 1990. Overview of the radiological accidents in the world, updated December 1989. International Journal of Radiation Biology 57:1073-1085.
132. Nenot JC. 1998. Radiation accidents: Lessons learnt for future radiological protection. International Journal of Radiation Biology 73:435-442.
133. Neta R. 1997. Modulation with cytokines of radiation injury: Suggested mechanisms of action. Environmental Health Perspectives 105(Suppl. 6):1463-1465.
134. Neta R, Okunieff P. 1996. Cytokine-induced radiation protection and sensitization. Seminars in Radiation Oncology 6:306-320.
135. Neta R, Oppenheim JJ. 1988. Cytokines in therapy of radiation injury. Blood 72:1093-1095.
136. Neta R, Stiefel SM, Finkelman F, Herrmann S, Ali N. 1994. IL- 12 protects bone marrow from and sensitizes intestinal tract to ionizing radiation. Journal of Immunology 153:4230-4237.
137. Neta R, Vogel SN, Oppenheim JJ, Douches SD. 1986. Cytokines in radioprotection. Comparison of the radioprotective effects of IL-1 to IL-2, GM-CSF and IFN gamma. Lymphokine Research 5(Suppl. 1):S105-110.
138. Nikula KJ, Muggenburg BA, Chang IY, Griffith WC, Hahn FF, Boecker BB. 1995. Biological effects of 137CsCl injected in beagle dogs. Radiation Research 142:347-361.
139. Nishimura Y, Kakuta I, Takeda H, Inaba J, Imai K, Watari K, Matsusaka N. 1994. Effect of natural chelating agents on the intestinal absorption of radiostrontium in rats. Radiation Protection Dosimetry 53:331-334.
140. Nolen RS. 2002. Dirty bombs, antimicrobials, and conservation. Journal of the American Veterinary Medical Association 220:1602,1607.
141. ONeill P, Wardman P. 2009. Radiation chemistry comes before radiation biology. International Journal of Radiation Biology 85:9-25.
142. Ohsawa I, Ishikawa M, Takahashi K, Watanabe M, Nishimaki K, Yamagata K, Katsura K, Katayama Y, Asoh S, Ohta S. 2007. Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals. Nature Medicine 13:688-694.
143. Ohtaki K. 1992. G-banding analysis of radiation-induced chromosome damage in lymphocytes of Hiroshima A-bomb survivors. Japanese Journal of Human Genetics 37:245-262.
144. Ohtaki K, Sposto R, Kodama Y, Nakano M, Awa AA. 1994. Aneuploidy in somatic cells of in utero exposed A-bomb survivors in Hiroshima. Mutation Research 316:49-58.
145. Omar RZ, Barber JA, Smith PG. 1999. Cancer mortality and morbidity among plutonium workers at the Sellafield plant of British Nuclear Fuels. British Journal of Cancer 79:1288-1301.
146. Ortega A, Domingo JL, Gomez M, Corbella J. 1989. Treatment of experimental acute uranium poisoning by chelating agents. Pharmacology and Toxicology 64:247-251.
147. Pan MH, Ho CT. 2008. Chemopreventive effects of natural dietary compounds on cancer development. Chemical Society Reviews 37:2558-2574.
148. Pandey BN. 2007. Drift from DNA-centric radiation targets: A paradigm shift in Radiation Biology. Indian Journal of Radiation Research 4:130-141.
149. Pandey BN, Lathika KM, Mishra KP. 2006. Modification of radiation induced oxidative damage in liposomal and microsomal membrane by eugenol. Radiation Physics and Chemistry 75:384-391.
150. Pandey BN, Mishra KP. 2004. Modification of thymocytes membrane radiooxidative damage and apoptosis by eugenol. Journal of Environmental, Pathology, Toxicology and Oncology 23:117-122.
151. Park JF, Buschbom RL, Dagle GE, James AC, Watson CR, Weller RE. 1997. Biological effects of inhaled 238PuO2 in beagles. Radiation Research 148:365-381.
152. Paul S, Amundson SA. 2008. Development of gene expression signatures for practical radiation biodosimetry. International Journal of Radiation Oncology. Biology and Physics 71:1236-1244.
153. Petroff DM. 2003. Responding to dirty bombs. Occupational Health and Safety 72:86-88.
154. Phan G, Le Gall B, Grillon G, Rouit E, Fouillit M, Benech H, Fattal E, Deverre JR. 2006. Enhanced decorporation of plutonium by DTPA encapsulated in small PEG-coated liposomes. Biochimie 88:1843-1849.
155. Pierce DA, Preston DL. 2000. Radiation-related cancer risks at low doses among atomic bomb survivors. Radiation Research 154:178-186.
156. Pierce DA, Shimizu Y, Preston DL, Vaeth M, Mabuchi K. 1996. Studies of the mortality of atomic bomb survivors. Report 12, Part I. Cancer: 1950-1990. Radiation Research 146:1-27. Potten CS. 1986. Biological dosimetry of local radiation accidents of skin: Possible cytological and biochemical methods. British Journal of Radiology (Suppl.) 19:82-85.
157. Pouget JP, Laurent C, Delbos M, Benderitter M, Clairand I, Trompier F, Stephanazzi J, Carsin H, Lambert F, Voisin P, Gourmelon P. 2004. PCC-FISH in skin fibroblasts for local dose assessment: Biodosimetric analysis of a victim of the Georgian radiological accident. Radiation Research 162:365-376.
158. Preston DL, Shimizu Y, Pierce DA, Suyama A, Mabuchi K. 2003. Studies of mortality of atomic bomb survivors. Report 13: Solid cancer and noncancer disease mortality: 1950-1997. Radiation Research 160:381-407.
159. Priest ND, Freemont A, Humphreys JA, Kathren RL. 1995. Histopathology and 241Am microdistribution in skeletal USTER Case 246. Health Physics 69:330-337.
160. Rahman YE. 1979. Potential of the liposomal approach to metal chelation therapy. Frontiers of Biology 48:625-652.
161. Rahman YE, Rosenthal MW, Cerny EA. 1973. Intracellular plutonium: Removal by liposome-encapsulated chelating agent. Science 180:300-302.
162. Ramalho AT, Costa ML, Oliveira MS. 1998. Conventional radiation-biological dosimetry using frequencies of unstable chromosome aberrations. Mutation Research 404:97-100.
163. Rastogi L, Feroz S, Pandey BN, Jagtap A, Mishra KP. 2010. Protection against radiation induced oxidative damage by an ethanolic extract of Nigella sativa L. International Journal of Radiation Biology (In Press).
164. Redman HC, McClellan RO, Jones RK, Boecker BB, Chiffelle TL, Pickrell JA, Rypka EW. 1972. Toxicity of 137CsCl in the beagle. Early biological effects. Radiation Research 50: 620-648.
165. Ring JP. 2004. Radiation risks and dirty bombs. Health Physics 86:S42-47.
166. Robbins J, Schneider AB. 2000. Thyroid cancer following exposure to radioactive iodine. Reviews in Endocrine and Metabolic Disorders 1:197-203.
167. Robinson B, Heid KR, Aldridge TL, Glenn RD. 1983. 1976 Hanford americium exposure incident: Organ burden and radiation dose estimates. Health Physics 45:911-921.
168. Rodrigues AS, Oliveira NG, Gil OM, Leonard A, Rueff J. 2005. Use of cytogenetic indicators in radiobiology. Radiation Protection Dosimetry 115:455-460.
169. Romanyukha A, Mitchell CA, Schauer DA, Romanyukha L, Swartz HM. 2007. Q-band EPR biodosimetry in tooth enamel microsamples: Feasibility test and comparison with x-band. Health Physics 93:631-635.
170. Romanyukha AA, Degteva MO, Kozheurov VP, Wieser A, Jacob P, Ignatiev EA, Vorobiova MI. 1996. Pilot study of the Urals population by tooth electron paramagnetic resonance dosimetry. Radiation and Environmental Biophysics 35:305-310.
171. Romanyukha AA, Seltzer SM, Desrosiers M, Ignatiev EA, Ivanov DV, Bayankin S, Degteva MO, Eichmiller FC, Wieser A, Jacob P. 2001. Correction factors in the EPR dose reconstruction for residents of the Middle and Lower Techa riverside. Health Physics 81:554-566.
172. Rosenthal MW, Rahman YE, Moretti ES, Cerny EA. 1975. Removal of polymeric plutonium by DTPA directed into cells by liposome encapsulation. Radiation Research 63: 262-274.
173. Saenko AS, Zamulaeva IA, Smirnova SG, Orlova NV, Selivanova EI, Matveeva NP, Kaplan MA, Nugis VY, Nadezhina NM, Tsyb AF. 2000. Determination of somatic mutant frequencies at glycophorin A and T-cell receptor loci for biodosimetry of acute and prolonged irradiation. Applied Radiation and Isotopes 52:1145-1148.
174. Salassidis K, Schmid E, Peter RU, Braselmann H, Bauchinger M. 1994. Dicentric and translocation analysis for retrospective dose estimation in humans exposed to ionising radiation during the Chernobyl nuclear power plant accident. Mutation Research 311:39-48.
175. Sandhya T, Lathika KM, Pandey BN, Bhilwade HN, Chaubey RC, Priyadarsini KI, Mishra KP. 2006. Protection against radiation oxidative damage in mice by Triphala. Mutation Research 609:17-25.
176. Schelling TC. 2006. An astonishing 60 years: The legacy of Hiroshima. Proceedings of the National Academy of Sciences of the USA 103:6089-6093.
177. Schoeters GE, Maisin JR, Vanderborght OL. 1991. Protracted treatment of C57B1 mice with Zn-DTPA after 241Am injection reduces the long-term radiation effects. International Journal of Radiation Biology 59:1027-1038.
178. Schuening FG, von Kalle C, Kiem HP, Appelbaum FR, Deeg HJ, Pepe M, Gooley T, Graham TC, Hackman RC, Storb R. 1997. Effect of recombinant canine stem cell factor, a c-kit ligand, on hematopoietic recovery after DLA-identical littermate marrow transplants in dogs. Experimental Hematology 25:1240-1245.
179. Shleien B, Halperin JA, Bilstad JM, Botstein P, Dutra EV Jr. 1983. Recommendations on the use of potassium iodide as a thyroidblocking agent in radiation accidents: An FDA update. Bulletin of the New York Academy of Medicine 59:1009-1019.
180. Snigiryova G, Braselmann H, Salassidis K, Shevchenko V, Bauchinger M. 1997. Retrospective biodosimetry of Chernobyl clean-up workers using chromosome painting and conventional chromosome analysis. International Journal of Radiation Biology 71:119-127.
181. Stahl SV, Fung E, Adams C, Lengqvist J, Mork B, Stenerlow B, Lewensohn R, Lehtio J, Zubarev R, Viktorsson K. 2009. Proteomics and pathway analysis identifies JNK-signaling as critical for High-LET radiation-induced apoptosis in non-small lung cancer cells. Molecular and Cellular Proteomics 8:1117-1129.
182. Stannard JN. 1989. Radioactivity and health: A history. Columbus, OH: Battelle Press.
183. Stara JF, Nelson NS, Della Rosa RJ, Bustad LK. 1968. Comparative metabolism of selected radionuclides in animals. Environmental Health Services (Radiological Health) 33:45-50.
184. Stara JF, Nelson NS, Della Rosa RJ, Bustad LK. 1971. Comparative metabolism of radionuclides in mammals: A review. Health Physics 20:113-137.
185. Stavem P, Brogger A, Devik F, Flatby J, van der Hagen CB, Henriksen T, Hoel PS, Host H, Kett K, Petersen B. 1985. Lethal acute gamma radiation accident at Kjeller, Norway. Report of a case. Acta Radiologica - Oncology 24:61-63.
186. Stradling GN, Gray SA, Pearce MJ, Wilson I, Moody JC, Burgada R, Durbin PW, Raymond KN. 1995. Decorporation of thorium-228 from the rat by 3,4,3-LIHOPO and DTPA after simulated wound contamination. Human and Experimental Toxicology 14:165-169.
187. Straume T, Langlois RG, Lucas J, Jensen RH, Bigbee WL, Ramalho AT, Brandao-Mello CE. 1991. Novel biodosimetry methods applied to victims of the Goiania accident. Health Physics 60:71-76.
188. Stsjazhko VA, Tsyb AF, Tronko ND, Souchkevitch G, Baverstock KF. 1995. Childhood thyroid cancer since accident at Chernobyl. British Medical Journal 310:801.
189. Suzuki K, Okada H, Yamauchi M, Oka Y, Kodama S, Watanabe M. 2006. Qualitative and quantitative analysis of phosphorylated ATM foci induced by low-dose ionizing radiation. Radiation Research 165:499-504.
190. Takahashi T, Fujimori K, Simon SL, Bechtner G, Edwards R, Trott KR. 1999. Thyroid nodules, thyroid function and dietary iodine in the Marshall Islands. International Journal of Epidemiology 28:742-749.
191. Takeoka M, Ward WF, Pollack H, Kamp DW, Panos RJ. 1997.KGF facilitates repair of radiation-induced DNA damage in alveolar epithelial cells. American Journal of Physiology 272:L1174-1180
192. Taylor DM, Stradling GN, Menetrier F. 2003. Biokinetics of radionuclides and treatment of accidental intakes. Radiation Protection Dosimetry 105:637-640.
193. Taylor GN, Lloyd RD,Mays CW, Angus W, Miller SC, Shabestari L, Hahn FF. 1991. Plutonium- or americium-induced liver tumors and lesions in beagles. Health Physics 61:337-347.
194. Tiwari P, Balakrishnan S, Kannan S, Kushwaha HS, Mishra KP. 2009. Thiol antioxidants protect against ionising radiationinduced micronuclei formation in cultured human lymphocytes. International Journal of Low Radiation 6:147-156.
195. Turai I. 2000. The IAEAs co-ordinated research project on biodosimetry, 1998-2000. Applied Radiation and Isotopes 52:1113-1116.
196. Tyburski JB, Patterson AD, Krausz KW, Slavik J, Fornace AJ Jr, Gonzalez FJ, Idle JR. 2008. Radiation metabolomics. 1. Identification of minimally invasive urine biomarkers for gamma- radiation exposure in mice. Radiation Research 170:1-14.
197. Tyburski JB, Patterson AD, Krausz KW, Slavik J, Fornace AJ, Jr, Gonzalez FJ, Idle JR. 2009. Radiation metabolomics. 2. Doseand time-dependent urinary excretion of deaminated purines and pyrimidines after sublethal gamma-radiation exposure in mice. Radiation Research 172:42-57.
198. Vastag B. 2003. Experts advise on potassium iodide use: No protection against dirty bombs. Journal of the American Medical Association 289:2058.
199. Voisin P, Roy L, Benderitter M. 2004. Why cant we find a better biological indicator of dose? Radiation Protection Dosimetry 112:465-469.
200. Volf V, Burgada R, Raymond KN, Durbin PW. 1993. Early chelation therapy for injected Pu-238 and Am-241 in the rat: Comparison of 3,4,3-LIHOPO, DFO-HOPO, DTPA-DX, DTPA and DFOA. International Journal of Radiation Biology 63:785-793.
201. Waselenko JK, MacVittie TJ, Blakely WF, Pesik N, Wiley AL, Dickerson WE, Tsu H, Confer DL, Coleman CN, Seed T, Lowry P, Armitage JO, Dainiak N. 2004. Medical management of the acute radiation syndrome: Recommendations of the Strategic National Stockpile Radiation Working Group. Annals of Internal Medicine 140:1037-1051.
202. Weisdorf D, Apperley J, Courmelon P, Gorin NC, Wingard JC, N. 2007. Radiation emergencies: Evaluation, management and transplantation. Biology of Blood and Marrow Transplantation 13:103-106.
203. Weiss JF, Landauer MR. 2003. Protection against ionizing radiation by antioxidant nutrients and phytochemicals. Toxicology 189:1-20.
204. Wieser A, Debuyst R, Fattibene P, Meghzifene A, Onori S, Bayankin SN, Brik A, Bugay A, Chumak V, Ciesielski B, Hoshi M, Imata H, Ivannikov A, Ivanov D, Junczewska M, Miyazawa C, Penkowski M, Pivovarov S, Romanyukha A, Romanyukha L, Schauer D, Scherbina O, Schultka K, Sholom S, Skvortsov V, Stepanenko V, Thomas JA, Tielewuhan E, Toyoda S, Trompier F. 2006. The Third International Intercomparison on EPR Tooth Dosimetry: Part 2, final analysis. Radiation Protection Dosimetry 120:176-183.
205. Wiggs LD, Johnson ER, Cox-DeVore CA, Voelz GL. 1994. Mortality through 1990 among white male workers at the Los Alamos National Laboratory: Considering exposures to plutonium and external ionizing radiation. Health Physics 67:577-588.
206. Williams D. 2008. Twenty years experience with post-Chernobyl thyroid cancer. Best Practice and Research Clinical Endocrinology and Metabolism 22:1061-1073.
207. Yamamotoa Y, Usudab N, Takatsujic T, Kuwaharaa Y, Fukumotoa M. 2009. Long incubation period for the induction of cancer by thorotrast is attributed to the uneven irradiation of liver cells at the microscopic level. Radiation Research 171:494-503.
208. Yokel RA, Fredenburg AM, Durbin PW, Xu J, Rayens MK, Raymond KN. 2000. The hexadentate hydroxypyridinonate TREN-(Me-3,2-HOPO) is a more orally active iron chelator than its bidentate analogue. Journal of Pharmaceutical Sciences 89:545-555.
209. Zamora ML, Tracy BL, Zielinski JM, Meyerhof DP, Moss MA. 1998. Chronic ingestion of uranium in drinking water: A study of kidney bioeffects in humans. Toxicological Sciences 43:68-77.
210. Zoetelief J, Broerse JJ. 1990. Dosimetry for radiation accidents: Present status and prospects for biological dosimeters. International Journal of Radiation Biology 57:737-750.